SCWorx Corp. (Nasdaq: WORX) announced today that it confirms previously disclosed plans to distribute COVID-19 Rapid Testing Units. Previously, the company announced receiving a committed purchase order from Rethink My Healthcare, a U.S.-based virtual healthcare network, for two million COVID-19 Rapid Testing Units, with provision for additional weekly orders of 2 million units for 23 weeks, valued at $35M per week.
Under the previously disclosed purchase order, SCWorx will supply Rethink My Healthcare with IgM/IgG Rapid Detection Kits. SCWorx continues to anticipate receiving the first 2 million rapid detection kits within approximately two weeks and looks forward to providing incremental updates as they become available.
States Move Forward to Better Protect Senior Citizens
Archer and REDA to Transform Newport Beach Building into Outpatient Center
Sunflower Medical Group Facing Lawsuit Following January Data Breach
Nemours Children's Health Opens New Location in Lake Nona
Enhancing Safety at Hennepin Healthcare with a Screening System